Learn more at LeadIQ.com

Insights

Diversified Technological Engines Evogene boasts three unique technological engines - MicroBoost AI, ChemPass AI, and GeneRator AI, focusing on microbes, small molecules, and genetic elements respectively. These cutting-edge technologies open doors for collaborations and sales opportunities across various industries.

Subsidiaries Leveraging Technologies Evogene's subsidiaries, such as Biomica Ltd., AgPlenus Ltd., and Lavie Bio Ltd., utilize the advanced technological engines to develop human microbiome-based therapeutics, ag-chemicals, and ag-biologicals. This offers a platform for partnerships and sales expansion within the life sciences sector.

Revenue Growth and Financial Stability The company has witnessed significant revenue growth, with total revenues reaching approximately $8.5 million in 2024. Evogene's strong financial health indicates capacity for investment and potential procurement deals, presenting lucrative sales opportunities for vendors and service providers.

Leadership Shifts Enhancing Business With the appointment of Nir Nimrodi as the new Chairperson of the Board, Evogene emphasizes continuity and strategic leadership. This change in leadership can open avenues for fresh collaborations, strategic alliances, and new sales partnerships in the biotechnology space.

Innovative Crop Protection Discoveries Through its subsidiary AgPlenus Ltd., Evogene announced the discovery of a new mode of action for fungicides against wheat disease. This innovation presents opportunities for partnerships with agricultural firms and agrochemical companies seeking sustainable crop protection solutions.

Similar companies to Evogene

Evogene Tech Stack

Evogene uses 8 technology products and services including Atlassian, Kubernetes, MySQL, and more. Explore Evogene's tech stack below.

Atlassian
Application Development & Management
Kubernetes
Containerization
MySQL
Database
Oracle
Enterprise
JavaScript
Programming Languages
HTTP/3
Web & Portal Technology
Google Analytics
Web Analytics
Apache
Web Servers

Media & News

Evogene's Email Address Formats

Evogene uses at least 1 format(s):

Evogene Email Formats	Example	Percentage
First.Last@evogene.com	John.Doe@evogene.com	80%
FirstL@evogene.com	JohnD@evogene.com	12%
Last@evogene.com	Doe@evogene.com	4%
First@evogene.com	John@evogene.com	4%

Frequently Asked Questions

Where is Evogene's headquarters located?

Evogene's main headquarters is located at 13 Gad Feinstein St. Rehovot, 76121 IL. The company has employees across 3 continents, including AsiaNorth AmericaEurope.

What is Evogene's phone number?

You can contact Evogene's main corporate office by phone at

+1-314-997-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Evogene's stock symbol?

Evogene is a publicly traded company; the company's stock symbol is EVGN.

What is Evogene's official website and social media links?

Evogene's official website is evogene.com and has social profiles on LinkedIn.

How much revenue does Evogene generate?

As of March 2025, Evogene's annual revenue reached $35M.

What is Evogene's SIC code NAICS code?

Evogene's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evogene have currently?

As of March 2025, Evogene has approximately 117 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Chief Product Officer: N. A.Chief Agronomist: R. G. ר. ג.Vice President Of Business Development: R. G.. Explore Evogene's employee directory with LeadIQ.

What industry does Evogene belong to?

Evogene operates in the Biotechnology Research industry.

What technology does Evogene use?

Evogene's tech stack includes AtlassianKubernetesMySQLOracleJavaScriptHTTP/3Google AnalyticsApache.

What is Evogene's email format?

Evogene's email format typically follows the pattern of . Find more Evogene email formats with LeadIQ.

How much funding has Evogene raised to date?

As of March 2025, Evogene has raised $5.5M in funding. The last funding round occurred on Aug 23, 2024 for $5.5M.

When was Evogene founded?

Evogene was founded in 2002.

Evogene

Evogene

Biotechnology ResearchRehovot, Israel51-200 Employees

Evogene (Nasdaq: EVGN, TASE: EVGN) is a computational biology company aiming to revolutionize the development of life-science based products by utilizing cutting edge technologies to increase probability of success while reducing development time and cost. Evogene established three unique technological engines – MicroBoost AI, ChemPass AI and GeneRator AI – leveraging Big Data and Artificial Intelligence and incorporating deep multidisciplinary understanding in life sciences. Each technological engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI). Evogene uses its technological engines to develop products through subsidiaries and with strategic partners. Currently, Evogene’s main subsidiaries utilize the technological engines to develop human microbiome-based therapeutics by Biomica Ltd., ag-chemicals by AgPlenus Ltd. and ag-biologicals by Lavie Bio Ltd. For more information, please visit: www.evogene.com

Company Overview

Headquarters: 13 Gad Feinstein St. Rehovot, 76121 IL
Phone number: +1-314-997-****
Website: evogene.com
SIC Code: 8731 - Commercial Physical and Biological Research
Stock Symbol: EVGN
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2002
Employees: 51-200

Media & News

Funding & Financials

$5.5M
Evogene has raised a total of $5.5M of funding over 9 rounds. Their latest funding round was raised on Aug 23, 2024 in the amount of $5.5M.
$10M$50M
Evogene's revenue is in the range of $10M$50M

Funding & Financials

$5.5M
Evogene has raised a total of $5.5M of funding over 9 rounds. Their latest funding round was raised on Aug 23, 2024 in the amount of $5.5M.
$10M$50M
Evogene's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.